Immunotherapy Strategies for Gastrointestinal Stromal Tumor

Immunotherapy Strategies for Gastrointestinal Stromal Tumor

Gastrointestinal stromal tumors (GIST) are the most common mesenchymal soft tissue sarcoma of the gastrointestinal tract. The management of locally advanced or metastatic unresectable GIST involves detecting KIT, PDGFR, or other molecular alterations targeted by imatinib and other tyrosine kinase in...

Full description

Bibliographic Details
Main Authors: Junaid Arshad, Philippos A. Costa, Priscila Barreto-Coelho, Brianna Nicole Valdes, Jonathan C. Trent
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:Cancers
Subjects:
gastrointestinal stromal tumors
GIST
immunotherapy
checkpoint inhibitors
antibodies
lymphocytes
Online Access:https://www.mdpi.com/2072-6694/13/14/3525

Internet

https://www.mdpi.com/2072-6694/13/14/3525

Similar Items